메뉴 건너뛰기




Volumn 10, Issue 4, 2010, Pages 267-276

Limb-girdle and congenital muscular dystrophies: Current diagnostics, management, and emerging technologies

Author keywords

Calf hypertrophy; Calpain deficiency; Caveolin; Collagen VI; Congenital muscular dystrophies; Creatine kinase; Diagnosis; Dysferlinopathies; Emery Dreifuss; Fukutin related protein; Hypotonia; Joint contractures; LARGE; Limb girdle muscular dystrophy; Merosin; Muscle glycosylation disorders; Muscular dystrophies; Myotilin; POMT; Sarcoglycanopathies; Telethonin; Titin; Treatment; Weakness

Indexed keywords

ALPHA CRYSTALLIN; ALPHA SARCOGLYCAN; ATALUREN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA CRYSTALLIN; BETA SARCOGLYCAN; CALPAIN 3; CAVEOLIN 3; COLLAGEN TYPE 6; CONNECTIN; CREATINE KINASE; CYCLOSPORIN; DEFLAZACORT; DELTA SARCOGLYCAN; DESMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; DYSFERLIN; DYSTROGLYCAN; DYSTROPHIN; EMERIN; FUKUTIN; FUKUTIN RELATED PROTEIN; GAMMA SARCOGLYCAN; LAMIN A; LAMIN C; PARVOVIRUS VECTOR; PLACEBO; STEROID; UNINDEXED DRUG;

EID: 77955864157     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0119-1     Document Type: Review
Times cited : (46)

References (46)
  • 1
    • 0028905205 scopus 로고
    • Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
    • Richard I, Broux O, Allamand V, et al.: Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell 1995, 81(1):27-40.
    • (1995) Cell , vol.81 , Issue.1 , pp. 27-40
    • Richard, I.1    Broux, O.2    Allamand, V.3
  • 2
    • 0033596817 scopus 로고    scopus 로고
    • Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population
    • Chou FL, Angelini C, Daentl D, et al.: Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population. Neurology 1999, 52(5):1015-1020.
    • (1999) Neurology , vol.52 , Issue.5 , pp. 1015-1020
    • Chou, F.L.1    Angelini, C.2    Daentl, D.3
  • 3
    • 0033361883 scopus 로고    scopus 로고
    • Calpainopathy-A survey of mutations and polymorphisms
    • Richard I, Roudaut C, Saenz A, et al.: Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet 1999, 64 (6):1524-1540.
    • (1999) Am J Hum Genet , vol.64 , Issue.6 , pp. 1524-1540
    • Richard, I.1    Roudaut, C.2    Saenz, A.3
  • 4
    • 17344365600 scopus 로고    scopus 로고
    • Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy
    • Liu J, Aoki M, Illa I, et al.: Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998, 20(1):31-36.
    • (1998) Nat Genet , vol.20 , Issue.1 , pp. 31-36
    • Liu, J.1    Aoki, M.2    Illa, I.3
  • 5
    • 17344363640 scopus 로고    scopus 로고
    • A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B
    • Bashir R, Britton S, Strachan T, et al.: A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet 1998, 20 (1):37-42.
    • (1998) Nat Genet , vol.20 , Issue.1 , pp. 37-42
    • Bashir, R.1    Britton, S.2    Strachan, T.3
  • 6
    • 34848917557 scopus 로고    scopus 로고
    • Distal anterior compartment myopathy with early ankle contractures
    • Saito H, Suzuki N, Ishiguro H, et al.: Distal anterior compartment myopathy with early ankle contractures. Muscle Nerve 2007, 36 (4):525-527.
    • (2007) Muscle Nerve , vol.36 , Issue.4 , pp. 525-527
    • Saito, H.1    Suzuki, N.2    Ishiguro, H.3
  • 7
    • 33746001621 scopus 로고    scopus 로고
    • Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies
    • Nguyen K, Bassez G, Bernard R, et al.: Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies. Hum Mutat 2005, 26(2):165.
    • (2005) Hum Mutat , vol.26 , Issue.2 , pp. 165
    • Nguyen, K.1    Bassez, G.2    Bernard, R.3
  • 8
    • 40449085244 scopus 로고    scopus 로고
    • Dysferlin deficiency enhances monocyte phagocytosis: A model for the inflammatory onset of limb-girdle muscular dystrophy 2B
    • Nagaraju K, Rawat R, Veszelovsky E, et al.: Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. Am J Pathol 2008, 172(3):774-785.
    • (2008) Am J Pathol , vol.172 , Issue.3 , pp. 774-785
    • Nagaraju, K.1    Rawat, R.2    Veszelovsky, E.3
  • 9
    • 55349124004 scopus 로고    scopus 로고
    • Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset
    • Kesari A, Fukuda M, Knoblach S, et al.: Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset. Am J Pathol 2008, 173 (5):1476-1487.
    • (2008) Am J Pathol , vol.173 , Issue.5 , pp. 1476-1487
    • Kesari, A.1    Fukuda, M.2    Knoblach, S.3
  • 10
    • 0028146869 scopus 로고
    • Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy
    • Roberds SL, Leturcq F, Allamand V, et al.: Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 1994, 78(4):625-633.
    • (1994) Cell , vol.78 , Issue.4 , pp. 625-633
    • Roberds, S.L.1    Leturcq, F.2    Allamand, V.3
  • 11
    • 0028971219 scopus 로고
    • Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
    • Bönnemann CG, Modi R, Noguchi S, et al.: Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet 1995, 11(3):266-273.
    • (1995) Nat Genet , vol.11 , Issue.3 , pp. 266-273
    • Bönnemann, C.G.1    Modi, R.2    Noguchi, S.3
  • 12
    • 0028971221 scopus 로고
    • Beta-sarcoglycan: Characterization and role in limb-girdle muscular dystrophy linked to 4q12
    • Lim LE, Duclos F, Broux O, et al.: Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 1995, 11(3):257-265.
    • (1995) Nat Genet , vol.11 , Issue.3 , pp. 257-265
    • Lim, L.E.1    Duclos, F.2    Broux, O.3
  • 13
    • 0028883973 scopus 로고
    • Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy
    • Noguchi S, McNally EM, Ben Othmane K, et al.: Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 1995, 270(5237):819-822.
    • (1995) Science , vol.270 , Issue.5237 , pp. 819-822
    • Noguchi, S.1    McNally, E.M.2    Ben Othmane, K.3
  • 14
    • 0029816797 scopus 로고    scopus 로고
    • Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene
    • Nigro V, de Sá Moreira E, Piluso G, et al.: Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996, 14 (2):195-198.
    • (1996) Nat Genet , vol.14 , Issue.2 , pp. 195-198
    • Nigro, V.1    De Sá Moreira, E.2    Piluso, G.3
  • 15
    • 18244375299 scopus 로고    scopus 로고
    • Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C
    • Brockington M, Yuva Y, Prandini P, et al.: Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001, 10(25):2851-2859.
    • (2001) Hum Mol Genet , vol.10 , Issue.25 , pp. 2851-2859
    • Brockington, M.1    Yuva, Y.2    Prandini, P.3
  • 16
    • 0037380737 scopus 로고    scopus 로고
    • Phenotypic spectrum associated with mutations in the fukutin-related protein gene
    • Mercuri E, Brockington M, Straub V, et al.: Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 2003, 53(4):537-542.
    • (2003) Ann Neurol , vol.53 , Issue.4 , pp. 537-542
    • Mercuri, E.1    Brockington, M.2    Straub, V.3
  • 17
    • 0036723943 scopus 로고    scopus 로고
    • Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin
    • Hackman P, Marchand S, Sarparanta J, et al.: Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 2002, 71(3):492-500.
    • (2002) Am J Hum Genet , vol.71 , Issue.3 , pp. 492-500
    • Hackman, P.1    Marchand, S.2    Sarparanta, J.3
  • 18
    • 34548794894 scopus 로고    scopus 로고
    • Phenotypic clustering of lamin A/C mutations in neuromuscular patients
    • Benedetti S, Menditto I, Degano M, et al.: Phenotypic clustering of lamin A/C mutations in neuromuscular patients. Neurology 2007, 69(12):1285-1292.
    • (2007) Neurology , vol.69 , Issue.12 , pp. 1285-1292
    • Benedetti, S.1    Menditto, I.2    Degano, M.3
  • 19
    • 39749098592 scopus 로고    scopus 로고
    • Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro
    • Traverso M, Gazzerro E, Assereto S, et al.: Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro. Lab Invest 2008, 88(3):275-283.
    • (2008) Lab Invest , vol.88 , Issue.3 , pp. 275-283
    • Traverso, M.1    Gazzerro, E.2    Assereto, S.3
  • 20
    • 0034284682 scopus 로고    scopus 로고
    • Myotilin is mutated in limb girdle muscular dystrophy 1A
    • Hauser MA, Horrigan S, Salmikangas P, et al.: Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet 2000, 9(14):2141-2147.
    • (2000) Hum Mol Genet , vol.9 , Issue.14 , pp. 2141-2147
    • Hauser, M.A.1    Horrigan, S.2    Salmikangas, P.3
  • 21
    • 32644441628 scopus 로고    scopus 로고
    • Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disrup- tion of Rb-MyoD pathways in muscle regeneration
    • Bakay M, Wang Z, Melcon G, et al.: Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disrup- tion of Rb-MyoD pathways in muscle regeneration. Brain 2006, 129:996-1013.
    • (2006) Brain , vol.129 , pp. 996-1013
    • Bakay, M.1    Wang, Z.2    Melcon, G.3
  • 22
    • 32144431571 scopus 로고    scopus 로고
    • Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration
    • Melcon G, Kozlov S, Cutler DA, et al.: Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum Mol Genet 2006,15(4):637-651.
    • (2006) Hum Mol Genet , vol.15 , Issue.4 , pp. 637-651
    • Melcon, G.1    Kozlov, S.2    Cutler, D.A.3
  • 23
    • 35148838670 scopus 로고    scopus 로고
    • Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I
    • Darin N, Krossmark A, Ahlander A, et al.: Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I. Eur J Paediatr Neurol 2007, 11(6):353-357.
    • (2007) Eur J Paediatr Neurol , vol.11 , Issue.6 , pp. 353-357
    • Darin, N.1    Krossmark, A.2    Ahlander, A.3
  • 24
    • 33845292617 scopus 로고    scopus 로고
    • Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy
    • Godfrey C, Escolar D, Brockington M, et al.: Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol 2006, 60(5):603-610.
    • (2006) Ann Neurol , vol.60 , Issue.5 , pp. 603-610
    • Godfrey, C.1    Escolar, D.2    Brockington, M.3
  • 25
    • 0031811334 scopus 로고    scopus 로고
    • Homozygous alphasarcoglycan mutation in two siblings: One asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient
    • Angelini C, Fanin M, Menegazzo, et al.: Homozygous alphasarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient. Muscle Nerve 1998; 21(6):769-775.
    • (1998) Muscle Nerve , vol.21 , Issue.6 , pp. 769-775
    • Angelini, C.1    Menegazzo, F.M.2
  • 26
    • 63449141811 scopus 로고    scopus 로고
    • Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs
    • This is the first report of dystrophinrestored expression in a dog model of DMD using morpholinos and delineates the rationale for its use in DMD patients
    • ••Yokota T, Lu QL, Partridge T, et al.: Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann Neurol 2009, 65(6):667-676. This is the first report of dystrophinrestored expression in a dog model of DMD using morpholinos and delineates the rationale for its use in DMD patients.
    • (2009) Ann Neurol , vol.65 , Issue.6 , pp. 667-676
    • Yokota, T.1    Lu, Q.L.2    Partridge, T.3
  • 27
    • 34247588271 scopus 로고    scopus 로고
    • PTC124 targets genetic disorders caused by nonsensemutations
    • This article explains the rationale for the use of PTC124 to increase the expression of dystrophin in patients with DMD
    • • Welch EM, Barton ER, Zhuo J, et al.: PTC124 targets genetic disorders caused by nonsensemutations. Nature 2007, 447(7140):87-91. This article explains the rationale for the use of PTC124 to increase the expression of dystrophin in patients with DMD.
    • (2007) Nature , vol.447 , Issue.7140 , pp. 87-91
    • Welch, E.M.1    Barton, E.R.2    Zhuo, J.3
  • 30
    • 0141925704 scopus 로고    scopus 로고
    • Glycosylation defects: A new mechanism for muscular dystrophy?
    • Grewal PK, Hewitt JE: Glycosylation defects: a new mechanism for muscular dystrophy? Hum Mol Genet 2003, 12(2):R259-R264.
    • (2003) Hum Mol Genet , vol.12 , Issue.2
    • Grewal, P.K.1    Hewitt, J.E.2
  • 31
    • 53049103155 scopus 로고    scopus 로고
    • Muscular dystrophies due to glycosylation defects
    • This article suggests that the overexpression of LARGE might be a potential therapeutic strategy in glycosylation defects
    • •• Muntoni F, Torelli S, Brockington M: Muscular dystrophies due to glycosylation defects. Neurotherapeutics 2008, 5(4):627-632.
    • (2008) Neurotherapeutics , vol.5 , Issue.4 , pp. 627-632
    • Muntoni, F.1    Torelli, S.2    Brockington, M.3
  • 32
    • 13844267667 scopus 로고    scopus 로고
    • Dystroglycan: Important player in skeletal muscle and beyond
    • Cohn RD: Dystroglycan: important player in skeletal muscle and beyond. Neuromuscul Disord 2005, 15(3):207-217.
    • (2005) Neuromuscul Disord , vol.15 , Issue.3 , pp. 207-217
    • Cohn, R.D.1
  • 33
    • 0842347675 scopus 로고    scopus 로고
    • EMG and nerve conduction studies in children with congenital muscular dystrophy
    • Quijano-Roy S, Renault F, Romero N, et al.: EMG and nerve conduction studies in children with congenital muscular dystrophy. Muscle Nerve 2004, 29(2):292-299.
    • (2004) Muscle Nerve , vol.29 , Issue.2 , pp. 292-299
    • Quijano-Roy, S.1    Renault, F.2    Romero, N.3
  • 34
    • 0344687355 scopus 로고    scopus 로고
    • 117th ENMC workshop: Ventilatory support in congenital neuromuscular disorders- congenital myopathies congenital muscular dystrophies congenital myotonic dystrophy and SMA (II) 4-6 April 2003 Naarden, the Netherlands
    • Wallgren-Pettersson C, Bushby K, Mellies U, et al.: 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders- congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands. Neuromuscul Disord 2004, 14(1):56-69.
    • (2004) Neuromuscul Disord , vol.14 , Issue.1 , pp. 56-69
    • Wallgren-Pettersson, C.1    Bushby, K.2    Mellies, U.3
  • 35
    • 58849108906 scopus 로고    scopus 로고
    • Cyclosporine A treatment for Ullrich congenital muscular dystrophy: A cellular study of mitochondrial dysfunction and its rescue
    • Hicks D, Lampe AK, Laval SH, et al.: Cyclosporine A treatment for Ullrich congenital muscular dystrophy: a cellular study of mitochondrial dysfunction and its rescue. Brain 2009, 132(1):147-155.
    • (2009) Brain , vol.132 , Issue.1 , pp. 147-155
    • Hicks, D.1    Lampe, A.K.2    Laval, S.H.3
  • 36
    • 59849085102 scopus 로고    scopus 로고
    • Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy
    • Méjat A, Decostre V, Li J, et al.: Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy. J Cell Biol 2009, 184(1):31-44.
    • (2009) J Cell Biol , vol.184 , Issue.1 , pp. 31-44
    • Méjat, A.1    Decostre, V.2    Li, J.3
  • 37
    • 0027985787 scopus 로고
    • Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy
    • Bione S, D'Adamo P, Maestrini E, et al.: Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994, 8(4):323-327.
    • (1994) Nat Genet , vol.8 , Issue.4 , pp. 323-327
    • Bione, S.1    D'Adamo, P.2    Maestrini, E.3
  • 38
    • 0036133645 scopus 로고    scopus 로고
    • 82nd ENMC international workshop 5th international Emery-Dreifuss muscular dystrophy (EDMD) workshop 1st Workshop of the MYOCLUSTER project EUROMEN (European muscle envelope nucleopathies) 15-16 September 2000, Naarden, the Netherlands
    • Bonne G, Capeau J, De Visser M, et al.: 82nd ENMC international workshop, 5th international Emery-Dreifuss muscular dystrophy (EDMD) workshop, 1st Workshop of the MYOCLUSTER project EUROMEN (European muscle envelope nucleopathies), 15-16 September 2000, Naarden, The Netherlands. Neuromuscul Disord 2002, 12(2):187-194.
    • (2002) Neuromuscul Disord , vol.12 , Issue.2 , pp. 187-194
    • Bonne, G.1    Capeau, J.2    De Visser, M.3
  • 39
    • 19044375929 scopus 로고    scopus 로고
    • Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: Reassessing the nosology of early-onset myopathies
    • Ferreiro A, Quijano-Roy S, Pichereau C, et al.: Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: reassessing the nosology of early-onset myopathies. Am J Hum Genet 2002, 71(4):739-749.
    • (2002) Am J Hum Genet , vol.71 , Issue.4 , pp. 739-749
    • Ferreiro, A.1    Quijano-Roy, S.2    Pichereau, C.3
  • 40
    • 0042164479 scopus 로고    scopus 로고
    • 108th ENMC international workshop 3rd workshop of the MYO-CLUSTER project: EUROMEN 7th international emery-dreifuss muscular dystrophy (EDMD) workshop 13-15 september 2002, Naarden, the Netherlands
    • Bonne G, Yaou RB, Béroud C, et al.: 108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands. Neuromuscul Disord 2003, 13(6):508-515.
    • (2003) Neuromuscul Disord , vol.13 , Issue.6 , pp. 508-515
    • Bonne, G.1    Yaou, R.B.2    Béroud, C.3
  • 41
    • 37049025556 scopus 로고    scopus 로고
    • Heart transplantation in patients with Emery-Dreifuss muscular dystrophy: Case reports
    • Dell'Amore A, Botta L, Martin Suarez S, et al.: Heart transplantation in patients with Emery-Dreifuss muscular dystrophy: case reports. Transplant Proc 2007, 39(10):3538-3540.
    • (2007) Transplant Proc , vol.39 , Issue.10 , pp. 3538-3540
    • Dell'Amore, A.1    Botta, L.2    Martin Suarez, S.3
  • 42
    • 58049209788 scopus 로고    scopus 로고
    • Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins
    • Muchir A, Shan J, Bonne G, et al.: Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet 2009, 18(2):241-247.
    • (2009) Hum Mol Genet , vol.18 , Issue.2 , pp. 241-247
    • Muchir, A.1    Shan, J.2    Bonne, G.3
  • 43
    • 72149108443 scopus 로고    scopus 로고
    • Diagnosis and management of Duchenne muscular dystrophy, part 1: Diagnosis, and pharmacological and psychosocial management
    • This article clearly delineates the current multidisciplinary approach to DMD, which may be extended to other types of progressive muscular dystrophy
    • •• Bushby K, Finkel R, Birnkrant DJ, et al.: Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010, 9(1):77-93. This article clearly delineates the current multidisciplinary approach to DMD, which may be extended to other types of progressive muscular dystrophy.
    • (2010) Lancet Neurol , vol.9 , Issue.1 , pp. 77-93
    • Bushby, K.1    Finkel, R.2    Birnkrant, D.J.3
  • 44
    • 76549130473 scopus 로고    scopus 로고
    • Diagnosis and management of Duchenne muscular dystrophy, part 2: Implementation of multidisciplinary care
    • This article clearly delineates the current multidisciplinary approach to DMD, which may be extended to other types of progressive muscular dystrophy
    • •• Bushby K, Finkel R, Birnkrant DJ, et al.: Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 2010, 9(2):177-189. This article clearly delineates the current multidisciplinary approach to DMD, which may be extended to other types of progressive muscular dystrophy.
    • (2010) Lancet Neurol , vol.9 , Issue.2 , pp. 177-189
    • Bushby, K.1    Finkel, R.2    Birnkrant, D.J.3
  • 45
    • 33845989867 scopus 로고    scopus 로고
    • Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy
    • Mayhew JE, Florence JM, Mayhew TP, et al.: Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle Nerve 2007, 35(1):36-42.
    • (2007) Muscle Nerve , vol.35 , Issue.1 , pp. 36-42
    • Mayhew, J.E.1    Florence, J.M.2    Mayhew, T.P.3
  • 46
    • 53249098299 scopus 로고    scopus 로고
    • Report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007
    • TREAT-NMD Neuromuscular Network. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD, Naarden, the Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, the Netherlands; Conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France
    • Mercuri E, Mayhew A, Muntoni F, et al.: TREAT-NMD Neuromuscular Network. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; report of three expert workshops: TREAT-NMD/ENMC workshop on outcome measures, 12th-13th May 2007, Naarden, The Netherlands; TREAT-NMD workshop on outcome measures in experimental trials for DMD, 30th June-1st July 2007, Naarden, The Netherlands; conjoint Institute of Myology TREAT-NMD meeting on physical activity monitoring in neuromuscular disorders, 11th July 2007, Paris, France. Neuromuscul Disord 2008,18(11):894-903.
    • (2008) Neuromuscul Disord , vol.18 , Issue.11 , pp. 894-903
    • Mercuri, E.1    Mayhew, A.2    Muntoni, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.